Michael Estivill
Overview
Explore the profile of Michael Estivill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huegel J, Dinh C, Martinelli M, Bracho O, Rosario R, Hardin H, et al.
Oncotarget
. 2022 Jul;
13:890-904.
PMID: 35875610
Neurofibromatosis Type 2 (NF2) is a rare tumor disorder caused by pathogenic variants of the merlin tumor suppressor encoded by . Patients develop vestibular schwannomas (VS), peripheral schwannomas, meningiomas, and...
2.
Effect of AR42 in Primary Vestibular Schwannoma Cells and a Xenograft Model of Vestibular Schwannoma
Misztal C, Bracho O, Bas E, Estivill M, Ivan M, Morcos J, et al.
Otol Neurotol
. 2022 Jun;
43(6):694-701.
PMID: 35761463
Hypothesis: AR42, a histone deacetylase (HDAC) inhibitor, reduces viability of primary vestibular schwannoma (VS) cells and delays tumor progression and hearing loss (HL) in a xenograft model of VS. Background:...
3.
Thielhelm T, Goncalves S, Welford S, Mellon E, Bracho O, Estivill M, et al.
Otol Neurotol
. 2021 Aug;
42(10):e1600-e1608.
PMID: 34420024
Hypothesis: Vestibular Schwannoma (VS) can avoid cell death following radiation injury by entering cell cycle arrest and activating RAD51-related DNA repair. Background: Although the radiobiology of various cancers is well-studied,...